+612 9045 4394
 
CHECKOUT
$7.95 Delivery per order to Australia and New Zealand
100% Australian owned
Over a hundred thousand in-stock titles ready to ship
Health Care Policy and Regulation : International Series in Intelligent Technologies - Thomas A. Abbott III

Health Care Policy and Regulation

International Series in Intelligent Technologies

By: Thomas A. Abbott III (Editor)

Hardcover Published: 28th February 1995
ISBN: 9780792395409
Number Of Pages: 261

Share This Book:

Hardcover

RRP $539.99
$373.95
31%
OFF
or 4 easy payments of $93.49 with Learn more
Ships in 7 to 10 business days

Earn 748 Qantas Points
on this Book

Other Available Editions (Hide)

  • Paperback View Product Published: 27th September 2012
    $227.94

5 care reforms. Part II: Price Regulation The second partofthis volume examines the role ofprice regulation in controlling health care costs. It contains three chapters. In chapter seven, I examine the alternatives for regulating pharmaceutical prices. In chapter eight, Jack Hadley examines the impactofvarious forms ofhospital price regulation; while in chapter nine,MarkPaulyexaminestheroleofpriceregulation incontrollingphysician fees. Chapter seven focuses on the issue of regulating pharmaceutical prices. There are two key issues examined in this paper. First, is there a clear need for price regulation, and second, can price regulation work in this industry? In response to the first question, I come to the conclusion that the proponents ofprice regulation have not really proven their case. Although the financial returns in the pharmaceu­ tical industry have been slightly higher than expected during the 1970s and 1980s, there is not overwhelming evidence of"price gouging" or excessive profits on the part of the industry. In response to the second question, the answer is clearly no. The traditional approaches to price regulation will not have the intended affect of eliminating excess profits from the industry while maintaining the incentives for research and development. First, rate-of-return regulation, the most natural approach, would result in many adverse incentives-includingexcessive investment in research and developmentinorderto inflatetheratebaseused tocalculatedtheallowablereturns.

Authors and Discussants
Preface and Acknowledgements
Introductionp. 1
Health Care Reformp. 11
Lessons from Public Utility Regulation for the Economic Regulation of Health Care Markets: An Overviewp. 13
Commentsp. 38
Commentsp. 41
Regulatory Strategies Under Managed Competition Health Care Reformsp. 45
Commentsp. 73
Health Care Cost Containment in Connecticutp. 81
Health Care Reform in New Jerseyp. 93
Health Security Act: Summary And Impactp. 97
Price Regulationp. 103
Regulating Pharmaceutical Pricesp. 105
Commentsp. 135
Hospital Price Regulation: Evidence and Implications for Health Care Reformp. 143
Paying Physicians as Agents: Fee-For-Service, Caption, Or Hybrids?p. 163
Commentsp. 175
Commentsp. 177
Quality Regulationp. 181
Medical Practice Guidelines and the Efficient Allocation of Resourcesp. 183
Commentsp. 200
Contending Views of Quality Management in Health Care: Implications for Competition and Regulationp. 205
Commentsp. 222
Commentsp. 224
Measuring and Improving Quality in Health Carep. 231
Commentsp. 236
Commentsp. 240
Glossaryp. 243
Table of Contents provided by Blackwell. All Rights Reserved.

ISBN: 9780792395409
ISBN-10: 0792395409
Series: International Series in Intelligent Technologies
Audience: Professional
Format: Hardcover
Language: English
Number Of Pages: 261
Published: 28th February 1995
Publisher: SPRINGER VERLAG GMBH
Country of Publication: NL
Dimensions (cm): 22.86 x 15.24  x 1.91
Weight (kg): 0.58
Edition Number: 3

Earn 748 Qantas Points
on this Book